(Q54389588)

29 May 2018

title

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model. (English)

1 reference

29 May 2018

1 reference

Hongju Wu

1

1 reference

29 May 2018

Yan Xin

2

1 reference

29 May 2018

Jing Zhao

3

1 reference

29 May 2018

Dan Sun

4

1 reference

29 May 2018

Wenhui Li

5

1 reference

29 May 2018

Yueyun Hu

6

1 reference

29 May 2018

Shasha Wang

7

1 reference

29 May 2018

publication date

3 February 2011

1 reference

29 May 2018

Cancer Chemotherapy and Pharmacology

published in

1 reference

29 May 2018

volume

68

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

879-887

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s00280-011-1563-6

exact match

0 references

cites work

New drugs in the treatment of gastric tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Anti-angiogenic effect of 5-Fluorouracil-based drugs against human colon cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Metronomic chemotherapy: changing the paradigm that more is better

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Review of docetaxel in the treatment of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Novel antivascular efficacy of metronomic docetaxel therapy in prostate cancer: hnRNP K as a player

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Antiangiogenic and anticolorectal cancer effects of metronomic irinotecan chemotherapy alone and in combination with semaxinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

The anti-angiogenic basis of metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

CD36 mediates the In vitro inhibitory effects of thrombospondin-1 on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Antiangiogenic effect of gemcitabine following metronomic administration in a pancreas cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Thrombospondin 1, a mediator of the antiangiogenic effects of low-dose metronomic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Vascular endothelial growth factor and bevacitumab in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Angiogenesis as targeted breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Metronomic low-dose oral cyclophosphamide and methotrexate plus or minus thalidomide in metastatic breast cancer: antitumor activity and biological effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Antiangiogenic effect of low-dose cyclophosphamide combined with ginsenoside Rg3 on Lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

Low-dose metronomic chemotherapy of paclitaxel synergizes with cetuximab to suppress human colon cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1563-6

10.1007/S00280-011-1563-6

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018